Active substanceMethionineMethionine
Similar drugsTo uncover
  • Methionine
    pills inwards 
    MARBIOFARM, OJSC     Russia
  • Methionine
    pills inwards 
    OZONE, LLC     Russia
  • Methionine
    pills inwards 
    AVVA RUS, OJSC     Russia
  • Methionine
    pills inwards 
  • Methionine
    pills inwards 
  • Dosage form: & nbspTwrappers covered with shell.
    Composition:For one tablet:

    methionine - 0.25 g.

    Auxiliary substances of the core: potato starch - 0,0382 g, stearic acid - 0,003 g, methylcellulose - 0,0034 g.

    Shell accessories: sucrose (sugar) 0.0826683 g, wheat flour 0.00371 g, magnesium hydroxycarbonate (magnesium carbonate basic) 0.010684 g, talc 0.001789 g, low molecular weight povidone 0.001088 g, azorubin (acidic red 2C for pharmaceutical purposes) - 0.0000087 g, paraffin liquid (vaseline oil) - 0.000026 g, beeswax - 0.000026 g.

    Description:

    Round tablets of biconvex form, covered with a shell of pink color. Marble is allowed. On the cross-section, two layers are visible, the inner one is white.

    Pharmacotherapeutic group:metabolic
    ATX: & nbsp

    A.05.B.A   Preparations for the treatment of liver diseases

    Pharmacodynamics:

    Has a metabolic, hepatoprotective effect. An indispensable amino acid - the donor of mobile methyl groups, is necessary for the synthesis of choline, the deficiency of which is associated with a disruption in the synthesis of phospholipids from fats and the deposition of neutral fat in the liver.

    Participates in the exchange of sulfur-containing amino acids, in the synthesis of epinephrine, creatinine and other biologically important compounds, activates the action of hormones, vitamins (B12, ascorbic, folic acid), enzymes, proteins, re-methylation reactions, deamination, decarboxylation, and others.

    It is necessary for detoxification of xenobiotics.

    When atherosclerosis reduces the concentration of cholesterol and increases the concentration of blood phospholipids.

    Pharmacokinetics:

    Easily absorbed from the intestine. It is excreted in small quantities in urine.

    Indications:

    In the complex therapy of liver diseases that occur with fatty infiltration of hepatocytes: toxic hepatitis, hepatosis (including alcohol), cirrhosis, liver dystrophy; intoxication.

    Prevention of toxic liver damage by arsenic, chloroform, benzene, alcohol.

    As part of combination therapy: protein deficiency of various origins, atherosclerosis, diabetes mellitus.

    Contraindications:

    Hypersensitivity, severe hepatic insufficiency, hepatic encephalopathy, viral hepatitis, hereditary intolerance to fructose, glucose-galactose malabsorption or sucrose-isomaltose insufficiency,children's age till 6 years.

    Carefully:

    Renal failure (risk of hyperaemia).

    Before use, consult a doctor.

    Pregnancy and lactation:

    When prescribing the drug, you must strictly follow the dosage.

    In the period of breastfeeding from the use of the drug, it is worthwhile to refrain, since there is no updated data.

    Dosing and Administration:

    Inside, for 1 / 2-1 hour before meals, 3-4 times a day.

    Adults: on 0,5-1,5 g.

    Children from 6 years and older: on 250 - 500 mg.

    The maximum single dose: adults - 1500 mg (6 tablets), children from 6 years of age and older - 500 mg (2 tablets).

    The maximum daily dose: adults - 6 g (24 tablets), children 6 years and older - 2 g (8 tablets).

    Course - daily for 10 - 30 days or 3 courses for 10 days with 10-day breaks.

    Side effects:

    Allergic reactions, nausea, vomiting (due to unpleasant odor and taste).

    Overdose:

    Symptoms: decrease in arterial pressure, tachycardia, disorientation.

    Treatment: symptomatic.

    Interaction:

    With simultaneous application with levodopa, its effectiveness decreases.

    Special instructions:

    It should be prescribed in balance with other amino acids.

    Unbalanced use of methionine in large doses can have a damaging effect on liver cells and other organs.

    Effect on the ability to drive transp. cf. and fur:

    When observing the dosing regimen, it does not affect the ability to drive vehicles and to engage in potentially hazardous activities that require an increased concentration of attention and speed of psychomotor reactions.

    Form release / dosage:The tablets covered with a cover, 250 mg.
    Packaging:

    10 tablets per contour cell packaging made of polyvinylchloride film and aluminum foil.

    50 tablets per can of polymeric materials.

    Each jar or 5 contour squares, together with the instruction for use, is placed in a pack of cardboard for consumer containers.

    Storage conditions:

    In a dry, protected from light place at a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    5 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:Without recipe
    Registration number:LP-002011
    Date of registration:25.02.2013
    Expiration Date:25.02.2018
    The owner of the registration certificate:MARBIOFARM, OJSC MARBIOFARM, OJSC Russia
    Manufacturer: & nbsp
    Representation: & nbspMARBIOFARM, OJSCMARBIOFARM, OJSC
    Information update date: & nbsp20.09.2016
    Illustrated instructions
      Instructions
      Up